Cargando…

Procalcitonin as a prognostic marker for sepsis based on SEPSIS‐3

BACKGROUND: The revised definition of sepsis is life‐threatening organ dysfunction caused by a dysregulated host response to infection (SEPSIS‐3). The objective of this study was to evaluate procalcitonin (PCT) for the diagnosis and prognosis of sepsis using SEPSIS‐3. METHODS: We enrolled 248 patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jekarl, Dong Wook, Lee, Seungok, Kim, Myungshin, Kim, Yonggoo, Woo, Seon Hee, Lee, Woon Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868407/ https://www.ncbi.nlm.nih.gov/pubmed/31420921 http://dx.doi.org/10.1002/jcla.22996

Ejemplares similares

Immune gene expression networks in sepsis: A network biology approach
por: Kim, Kyung Soo, et al.
Publicado: (2021)

Diagnosis and Prognosis of Sepsis Based on Use of Cytokines, Chemokines, and Growth Factors
por: Jekarl, Dong Wook, et al.
Publicado: (2019)

Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma
por: Jekarl, Dong Wook, et al.
Publicado: (2019)

Correction: Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma
por: Jekarl, Dong Wook, et al.
Publicado: (2020)

Regulatory Mechanism between Ferritin and Mitochondrial Reactive Oxygen Species in Spinal Ligament-Derived Cells from Ossification of Posterior Longitudinal Ligament Patient
por: Kim, Jong Tae, et al.
Publicado: (2023)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Identification of Compound Heterozygous Mutations in the BBS7 Gene in a Korean Family with Bardet-Biedl Syndrome
por: Shin, Seok Joon, et al.
Publicado: (2015)

Passage-dependent accumulation of somatic mutations in mesenchymal stromal cells during in vitro culture revealed by whole genome sequencing
por: Kim, Myungshin, et al.
Publicado: (2017)

Tissue-specific Differentiation Potency of Mesenchymal Stromal Cells from Perinatal Tissues
por: Kwon, Ahlm, et al.
Publicado: (2016)

Performance evaluation of presepsin using a Sysmex HISCL‐5000 analyzer and determination of reference interval
por: Kang, Taewon, et al.
Publicado: (2022)

Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock
por: Hu, Chenggong, et al.
Publicado: (2017)

Ubiquitin C decrement plays a pivotal role in replicative senescence of bone marrow mesenchymal stromal cells
por: Kim, Jiyeon, et al.
Publicado: (2018)

Prevalence of p16 Methylation and Prognostic Factors in Plasma Cell Myeloma at a Single Institution in Korea
por: Kim, Hyunjung, et al.
Publicado: (2013)

Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients
por: Jekarl, Dong Wook, et al.
Publicado: (2018)

Procalcitonin as a prognostic marker for sepsis: a prospective observational study
por: Jain, Saransh, et al.
Publicado: (2014)

Procalcitonin kinetics as a prognostic marker in severe sepsis/septic shock
por: Poddar, Banani, et al.
Publicado: (2015)

Serum procalcitonin as a diagnostic marker of neonatal sepsis
por: Park, In Ho, et al.
Publicado: (2014)

Indirect Method for Estimation of Reference Intervals of Inflammatory Markers
por: Kang, Taewon, et al.
Publicado: (2023)

Evaluating Diagnostic Tests for Helicobacter pylori Infection Without a Reference Standard: Use of Latent Class Analysis
por: Jekarl, Dong Wook, et al.
Publicado: (2020)

Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

Procalcitonin as a marker of bacterial sepsis in immunocompromised patients
por: Gatserelia, Lana, et al.
Publicado: (2012)

Procalcitonin: A Reliable Marker for the Diagnosis of Neonatal Sepsis
por: Adib, Minoo, et al.
Publicado: (2012)

Evaluation of procalcitonin as a diagnostic and prognostic marker in patients with sepsis, severe sepsis and septic shock associated with ventilator-associated pneumonia
por: Virtzili, S, et al.
Publicado: (2005)

Procalcitonin as an adjunctive biomarker in sepsis
por: Sinha, Mahua, et al.
Publicado: (2011)

Procalcitonin in autoimmune disease with sepsis
por: Leonhardt, U, et al.
Publicado: (2001)

Significance of serum procalcitonin in sepsis
por: Sudhir, Uchil, et al.
Publicado: (2011)

Procalcitonin Is a Marker of Gram-Negative Bacteremia in Patients With Sepsis
por: Guo, Shun Yuan, et al.
Publicado: (2015)

Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
por: Vijayan, Ashitha L., et al.
Publicado: (2017)

Procalcitonin as a prognostic biomarker of severe sepsis and septic shock
por: de Azevedo, JRA, et al.
Publicado: (2013)

Diagnostic Value and Prognostic Use of Presepsin Versus Procalcitonin in Sepsis
por: Venugopalan, Deepak P, et al.
Publicado: (2019)

Prognostic value of platelet combined with serum procalcitonin in patients with sepsis
por: Chen, Jianhui, et al.
Publicado: (2023)

Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis
por: Tambo, Mitsuhiro, et al.
Publicado: (2020)

Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock
por: Huang, Min-Yi, et al.
Publicado: (2016)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions
por: Lee, Sukyo, et al.
Publicado: (2022)

JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia
por: Jekarl, Dong Wook, et al.
Publicado: (2010)

Risk stratification by 30-day prognostic factors of clinical outcomes after granulocyte transfusion in acute myeloid leukemia: A single-center retrospective study
por: Yoo, Jaeeun, et al.
Publicado: (2022)

Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis
por: Kim, Hanah, et al.
Publicado: (2017)

Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin
por: López Sastre, José B, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6pof99f3d6k2a1hsk2mb8h3qg3